content: <?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:com="http://www.sec.gov/edgar/common">
    <headerData>
      <submissionType>144</submissionType>
      <filerInfo>
        <filer>
          <filerCredentials>
            <cik>0001856296</cik>
            <ccc>XXXXXXXX</ccc>
          </filerCredentials>
        </filer>
        <liveTestFlag>LIVE</liveTestFlag>
  
  
      </filerInfo>
    </headerData>
    <formData>
      <issuerInfo>
        <issuerCik>0001635088</issuerCik>
        <issuerName>Roivant Sciences Ltd.</issuerName>
        <secFileNumber>001-40782</secFileNumber>
        <issuerAddress>
          <com:street1>CLARENDON HOUSE, 2 CHURCH STREET</com:street1>
          <com:city>HAMILTON HM11</com:city>
          <com:stateOrCountry>D0</com:stateOrCountry>
          <com:zipCode>HM11</com:zipCode>
        </issuerAddress>
        <issuerContactPhone>441-295-5950</issuerContactPhone>
        <nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>Kumar Rakhi</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
        <relationshipsToIssuer>
          <relationshipToIssuer>Officer</relationshipToIssuer>
        </relationshipsToIssuer>
      </issuerInfo>
      <securitiesInformation>
        <securitiesClassTitle>Common</securitiesClassTitle>
        <brokerOrMarketmakerDetails>
          <name>Rockefeller Financial LLC</name>
          <address>
            <com:street1>45 Rockefeller Plaza</com:street1>
            <com:street2>Floor 5</com:street2>
            <com:city>New York</com:city>
            <com:stateOrCountry>NY</com:stateOrCountry>
            <com:zipCode>10111</com:zipCode>
          </address>
        </brokerOrMarketmakerDetails>
        <noOfUnitsSold>336</noOfUnitsSold>
        <aggregateMarketValue>4032.00</aggregateMarketValue>
        <noOfUnitsOutstanding>766811433</noOfUnitsOutstanding>
        <approxSaleDate>08/01/2023</approxSaleDate>
        <securitiesExchangeName>NASDAQ</securitiesExchangeName>
      </securitiesInformation>
      <securitiesToBeSold>
        <securitiesClassTitle>Common Shares</securitiesClassTitle>
        <acquiredDate>08/01/2023</acquiredDate>
        <natureOfAcquisitionTransaction>Options Exercise- Grant Date- 5/22/2017</natureOfAcquisitionTransaction>
        <nameOfPersonfromWhomAcquired>Roivant Sciences Ltd</nameOfPersonfromWhomAcquired>
        <isGiftTransaction>N</isGiftTransaction>
        <amountOfSecuritiesAcquired>336</amountOfSecuritiesAcquired>
        <paymentDate>08/01/2023</paymentDate>
        <natureOfPayment>Wire</natureOfPayment>
      </securitiesToBeSold>
      <nothingToReportFlagOnSecuritiesSoldInPast3Months>N</nothingToReportFlagOnSecuritiesSoldInPast3Months>
      <securitiesSoldInPast3Months>
        <sellerDetails>
          <name>Rakhi Kumar c/o Roivant Sciences Ltd.</name>
          <address>
            <com:street1>7th Floor 50 broadway</com:street1>
            <com:city>london</com:city>
            <com:stateOrCountry>X0</com:stateOrCountry>
            <com:zipCode>SW1H0DB</com:zipCode>
          </address>
        </sellerDetails>
        <securitiesClassTitle>Common Shares</securitiesClassTitle>
        <saleDate>05/01/2023</saleDate>
        <amountOfSecuritiesSold>62219</amountOfSecuritiesSold>
        <grossProceeds>533974.37</grossProceeds>
      </securitiesSoldInPast3Months>
      <securitiesSoldInPast3Months>
        <sellerDetails>
          <name>Rakhi Kumar c/o Roivant Sciences Ltd.</name>
          <address>
            <com:street1>7th Floor 50 broadway</com:street1>
            <com:city>london</com:city>
            <com:stateOrCountry>X0</com:stateOrCountry>
            <com:zipCode>SW1H0DB</com:zipCode>
          </address>
        </sellerDetails>
        <securitiesClassTitle>Common Shares</securitiesClassTitle>
        <saleDate>05/02/2023</saleDate>
        <amountOfSecuritiesSold>15517</amountOfSecuritiesSold>
        <grossProceeds>130685.55</grossProceeds>
      </securitiesSoldInPast3Months>
      <securitiesSoldInPast3Months>
        <sellerDetails>
          <name>Rakhi Kumar c/o Roivant Sciences Ltd.</name>
          <address>
            <com:street1>7th Floor 50 broadway</com:street1>
            <com:city>london</com:city>
            <com:stateOrCountry>X0</com:stateOrCountry>
            <com:zipCode>SW1H0DB</com:zipCode>
          </address>
        </sellerDetails>
        <securitiesClassTitle>Common Shares</securitiesClassTitle>
        <saleDate>05/23/2023</saleDate>
        <amountOfSecuritiesSold>1557</amountOfSecuritiesSold>
        <grossProceeds>14916.06</grossProceeds>
      </securitiesSoldInPast3Months>
      <securitiesSoldInPast3Months>
        <sellerDetails>
          <name>Rakhi Kumar c/o Roivant Sciences Ltd.</name>
          <address>
            <com:street1>7th Floor 50 broadway</com:street1>
            <com:city>london</com:city>
            <com:stateOrCountry>X0</com:stateOrCountry>
            <com:zipCode>SW1H0DB</com:zipCode>
          </address>
        </sellerDetails>
        <securitiesClassTitle>Common Shares</securitiesClassTitle>
        <saleDate>06/09/2023</saleDate>
        <amountOfSecuritiesSold>43893</amountOfSecuritiesSold>
        <grossProceeds>435726.62</grossProceeds>
      </securitiesSoldInPast3Months>
      <securitiesSoldInPast3Months>
        <sellerDetails>
          <name>Rakhi Kumar c/o Roivant Sciences Ltd.</name>
          <address>
            <com:street1>7th Floor 50 broadway</com:street1>
            <com:city>london</com:city>
            <com:stateOrCountry>X0</com:stateOrCountry>
            <com:zipCode>SW1H0DB</com:zipCode>
          </address>
        </sellerDetails>
        <securitiesClassTitle>Common Shares</securitiesClassTitle>
        <saleDate>06/22/2023</saleDate>
        <amountOfSecuritiesSold>1357</amountOfSecuritiesSold>
        <grossProceeds>13583.57</grossProceeds>
      </securitiesSoldInPast3Months>
      <securitiesSoldInPast3Months>
        <sellerDetails>
          <name>Rakhi Kumar c/o Roivant Sciences Ltd.</name>
          <address>
            <com:street1>7th Floor 50 broadway</com:street1>
            <com:city>london</com:city>
            <com:stateOrCountry>X0</com:stateOrCountry>
            <com:zipCode>SW1H0DB</com:zipCode>
          </address>
        </sellerDetails>
        <securitiesClassTitle>Common Shares</securitiesClassTitle>
        <saleDate>07/14/2023</saleDate>
        <amountOfSecuritiesSold>535</amountOfSecuritiesSold>
        <grossProceeds>6420.00</grossProceeds>
      </securitiesSoldInPast3Months>
      <securitiesSoldInPast3Months>
        <sellerDetails>
          <name>Rakhi Kumar c/o Roivant Sciences Ltd.</name>
          <address>
            <com:street1>7th Floor 50 broadway</com:street1>
            <com:city>london</com:city>
            <com:stateOrCountry>X0</com:stateOrCountry>
            <com:zipCode>SW1H0DB</com:zipCode>
          </address>
        </sellerDetails>
        <securitiesClassTitle>Common Shares</securitiesClassTitle>
        <saleDate>07/18/2023</saleDate>
        <amountOfSecuritiesSold>100</amountOfSecuritiesSold>
        <grossProceeds>1200.00</grossProceeds>
      </securitiesSoldInPast3Months>
      <securitiesSoldInPast3Months>
        <sellerDetails>
          <name>Rakhi Kumar c/o Roivant Sciences Ltd.</name>
          <address>
            <com:street1>7th Floor 50 broadway</com:street1>
            <com:city>london</com:city>
            <com:stateOrCountry>X0</com:stateOrCountry>
            <com:zipCode>SW1H0DB</com:zipCode>
          </address>
        </sellerDetails>
        <securitiesClassTitle>Common Shares</securitiesClassTitle>
        <saleDate>07/24/2023</saleDate>
        <amountOfSecuritiesSold>1393</amountOfSecuritiesSold>
        <grossProceeds>15309.07</grossProceeds>
      </securitiesSoldInPast3Months>
      <remarks>The shares reported on this Form 144 will be sold pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 02/25/2023.</remarks>
      <noticeSignature>
        <noticeDate>08/01/2023</noticeDate>
        <planAdoptionDates>
          <planAdoptionDate>02/25/2023</planAdoptionDate>
        </planAdoptionDates>
        <signature>/s/ Christian Nasser, as a duly authorized representative of National Financial Services LLC, as attorney-in-fact for Rakhi Kumar</signature>
      </noticeSignature>
    </formData>
  </edgarSubmission>
metadata_documents: [{"type": "144", "sequence": "1", "filename": "primary_doc.xml", "secsgml_size_bytes": 8102}]
text: 144
  0001856296
  XXXXXXXX
  LIVE
  0001635088
  Roivant Sciences Ltd.
  001-40782
  CLARENDON HOUSE, 2 CHURCH STREET
  HAMILTON HM11
  D0
  HM11
  441-295-5950
  Kumar Rakhi
  Officer
  Common
  Rockefeller Financial LLC
  45 Rockefeller Plaza
  Floor 5
  New York
  NY
  10111
  336
  4032.00
  766811433
  08/01/2023
  NASDAQ
  Common Shares
  08/01/2023
  Options Exercise- Grant Date- 5/22/2017
  Roivant Sciences Ltd
  N
  336
  08/01/2023
  Wire
  N
  Rakhi Kumar c/o Roivant Sciences Ltd.
  7th Floor 50 broadway
  london
  X0
  SW1H0DB
  Common Shares
  05/01/2023
  62219
  533974.37
  Rakhi Kumar c/o Roivant Sciences Ltd.
  7th Floor 50 broadway
  london
  X0
  SW1H0DB
  Common Shares
  05/02/2023
  15517
  130685.55
  Rakhi Kumar c/o Roivant Sciences Ltd.
  7th Floor 50 broadway
  london
  X0
  SW1H0DB
  Common Shares
  05/23/2023
  1557
  14916.06
  Rakhi Kumar c/o Roivant Sciences Ltd.
  7th Floor 50 broadway
  london
  X0
  SW1H0DB
  Common Shares
  06/09/2023
  43893
  435726.62
  Rakhi Kumar c/o Roivant Sciences Ltd.
  7th Floor 50 broadway
  london
  X0
  SW1H0DB
  Common Shares
  06/22/2023
  1357
  13583.57
  Rakhi Kumar c/o Roivant Sciences Ltd.
  7th Floor 50 broadway
  london
  X0
  SW1H0DB
  Common Shares
  07/14/2023
  535
  6420.00
  Rakhi Kumar c/o Roivant Sciences Ltd.
  7th Floor 50 broadway
  london
  X0
  SW1H0DB
  Common Shares
  07/18/2023
  100
  1200.00
  Rakhi Kumar c/o Roivant Sciences Ltd.
  7th Floor 50 broadway
  london
  X0
  SW1H0DB
  Common Shares
  07/24/2023
  1393
  15309.07
  The shares reported on this Form 144 will be sold pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 02/25/2023.
  08/01/2023
  02/25/2023
  /s/ Christian Nasser, as a duly authorized representative of National Financial Services LLC, as attorney-in-fact for Rakhi Kumar